Study of LY573636-sodium in Essential Thrombocythemia and Acute Myeloid Leukemia

Summary

The purpose of this study is to determine a safe dose of LY573636-sodium to be given to patients with acute myeloid leukemia and to determine any side effects that may be associated with LY573636-sodium in this patient population. Efficacy measures will also be used to assess the activity of LY573636-sodium in acute myeloid leukemia and essential thrombocythemia patients.

Timeline

Start

2008-08

Primary completion

2011-12

Completion

2011-12

Drugs

Indications